Enhanced Telomerase-Activating Compounds for Fertility and Related Applications

This inventive concept discloses improved telomerase-activating compounds and compositions for treating diseases, disorders, and conditions related to fertility and preserving same. The new claims provide enhanced formulations, dosing regimens, and combinations with fertility-promoting agents to optimize telomerase expression and activity, leading to better fertility outcomes.

The original patent disclosed telomerase-activating compounds for fertility and related applications, but had limitations in terms of optimizing telomerase expression, controlling dosing, and addressing individual variability. The new inventive concept addresses these limitations by introducing controlled-release formulations, personalized dosing regimens, and combinations with antioxidants and fertility-promoting agents.

The new inventive concept comprises a system for enhancing fertility in a subject, featuring a telomerase-activating compound and a fertility-promoting agent. The telomerase-activating compound is administered in a controlled-release formulation to optimize telomerase expression and activity. Additionally, a method for improving fertility outcomes in a subject involves administering a telomerase-activating compound in a personalized dosage regimen based on the subject's individual telomerase expression profile. Furthermore, a composition for promoting fertility in a subject includes a telomerase-activating compound and an antioxidant, which enhances the bioavailability and efficacy of the telomerase-activating compound.

The new claims introduce novel combinations of telomerase-activating compounds with fertility-promoting agents, controlled-release formulations, and personalized dosing regimens, which are not obvious from the original patent. These improvements provide a significant enhancement to the original inventive concept, making it more effective and efficient.

Alternative embodiments of the inventive concept could include different formulations, such as oral, injectable, or topical, and various combinations of telomerase-activating compounds with other fertility-promoting agents. Additionally, the inventive concept could be adapted for use in other applications, such as cancer treatment or regenerative medicine.

The enhanced telomerase-activating compounds and compositions have significant commercial potential in the fertility and reproductive health markets, as well as in related industries such as cancer treatment and regenerative medicine. The target market includes pharmaceutical companies, biotechnology firms, and healthcare providers specializing in fertility and reproductive health.